Review
Published on 15 Jan 2025
Chinese and western medicine treatment of myocardial fibrosis drugs
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1477601
Type at least 3 characters
84 articles
Articles
Systematic Review
Published on 14 Jan 2025
Comparative efficacy of different drugs in acute heart failure with renal dysfunction: a systematic review and network meta-analysis
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1444068
- 106 views
Editorial
Published on 07 Jan 2025
Editorial: Novel treatments for cardiovascular diseases by targeting inflammation, oxidative stress, and cell death
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1538222
- 217 views
Original Research
Published on 06 Jan 2025
Effects of different doses of remimazolam on the quality of sedation and cardiac function in elderly patients: a double-blind randomised controlled study
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1453608
- 357 views
Systematic Review
Accepted on 27 Dec 2024
Efficacy and Safety of Cardiac Myosin Inhibitors for Symptomatic Hypertrophic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1477487
Review
Published on 03 Dec 2024
Traditional Chinese medicine for cardiovascular disease: efficacy and safety
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1419169
- 782 views
Systematic Review
Published on 22 Nov 2024
Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1474472
- 1,072 views
Original Research
Published on 29 Oct 2024
Metabolomics revealed pharmacodynamic effects of aspirin and indobufen in patients after percutaneous transluminal angioplasty surgery
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1433643
- 468 views
Original Research
Published on 24 Oct 2024
Simultaneous determination of the combined and free concentrations of atorvastatin and its major metabolite in vitro and in vivo based on ultrafiltration coupled with UPLC-MS/MS method: an application in a protein binding rate and metabolism ability study in uremic hemodialysis patients
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1461181
- 627 views
Review
Published on 18 Oct 2024
Research progress of sea buckthorn (Hippophae rhamnoides L.) in prevention and treatment of cardiovascular disease
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1477636
- 1,533 views
Systematic Review
Published on 25 Sep 2024
The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors combined with statins in patients with hypercholesterolemia: a network meta-analysis
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1454918
- 1,592 views
Original Research
Published on 24 Sep 2024
Causal relationship between novel antidiabetic drugs and ischemic stroke: a drug-targeted Mendelian randomization study
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1449185
- 1,352 views
Review
Published on 23 Sep 2024
A comprehensive review of finerenone—a third-generation non-steroidal mineralocorticoid receptor antagonist
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1476029
- 2,834 views
Mini Review
Published on 11 Sep 2024
Unveiling the role of TRPA1 in cardiovascular health and disease: a mini review
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1416698
- 1,048 views
Review
Published on 06 Sep 2024
Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1439696
- 4,263 views
Editorial
Published on 04 Sep 2024
Editorial: Nutraceuticals in cardiovascular diseases and their associated risk conditions
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1468355
- 593 views